How to Run VIP Cycle — Safe Protocol Guide

Most people who start a VIP cycle never make it past week four with meaningful results. Not because the peptides don't work, but because they bypass the receptor priming phase and go straight to saturation dosing. The VIP protocol (Vasoactive Intestinal Peptide stacked with growth hormone secretagogues like GHRP-2 and GHRP-6) works by amplifying endogenous GH pulses, but only if the somatotroph cells in your anterior pituitary haven't been desensitised by poorly timed administration. Skip the escalation window and you'll plateau by day 18. We've seen it happen across hundreds of research contexts.

Our team works directly with researchers designing peptide protocols for metabolic studies, recovery investigations, and body composition trials. The gap between a protocol that delivers sustained GH elevation and one that stalls out comes down to three variables most online guides never address: micro-dosing escalation in the first two weeks, meal timing relative to injection windows, and off-cycle duration calibrated to receptor recovery rates.

How do you run a VIP cycle correctly?

To run a VIP cycle effectively, begin with GHRP-2 at 100mcg and GHRP-6 at 100mcg administered together three times daily on an empty stomach, spaced at least three hours apart. Escalate by 50mcg increments every four days during weeks one and two, reaching therapeutic dose (200–300mcg per peptide) by day fourteen. Run the stack for eight weeks, then implement a mandatory four-week washout to allow somatotroph receptor re-sensitisation before beginning another cycle.

The VIP cycle isn't a single peptide. It's a strategic stack. Most protocols layer a growth hormone secretagogue (GHRP-2 or GHRP-6) with a GHRH analogue or VIP itself to create synergistic pituitary stimulation. The common mistake is treating this like a linear dosing schedule when the mechanism is pulsatile. Your anterior pituitary releases GH in discrete pulses every 3–4 hours under normal conditions. The peptides amplify those pulses, they don't replace them. This article covers the exact escalation structure, injection timing relative to circadian GH peaks, troubleshooting receptor fatigue, and what to do when results stall mid-cycle.

Step 1: Select Your Base Stack (GHRP-2 + GHRP-6 or Alternatives)

The foundational decision in any VIP cycle is peptide pairing. Specifically, which growth hormone secretagogue you combine with VIP or use as your primary driver if you're running a GHRP-only protocol. GHRP-2 and GHRP-6 are the most common base choices because they stimulate GH release through the ghrelin receptor (GHS-R1a) without the appetite surge that makes ipamorelin impractical for fat loss contexts. GHRP-2 produces cleaner, more predictable GH pulses with less cortisol co-release than GHRP-6, but GHRP-6 tends to amplify the anabolic response in muscle tissue due to secondary IGF-1 signalling.

If you're stacking with actual VIP (vasoactive intestinal peptide), the mechanism shifts. VIP acts on VPAC receptors in the hypothalamus to enhance GHRH release, creating an upstream amplification effect rather than direct pituitary stimulation. This dual-pathway approach (VIP for GHRH amplification + GHRP for direct somatotroph activation) produces larger GH peaks but requires tighter timing discipline because both peptides have short half-lives (VIP degrades within 2–3 minutes in plasma, GHRP-2 within 20–30 minutes). Most researchers using this stack administer VIP 10–15 minutes before the GHRP dose to allow the GHRH surge to precede direct pituitary stimulation.

Alternative stacks include pairing GHRP-2 with a longer-acting GHRH analogue like CJC-1295 (with or without DAC). The DAC version (Drug Affinity Complex) extends half-life to 6–8 days, which allows twice-weekly dosing instead of three-times-daily. But it sacrifices the pulsatile release pattern that makes short-acting peptides effective for replicating natural GH physiology. For most applications, the GHRP-2 + GHRP-6 combination delivers the most reliable results without requiring VIP's rapid degradation management.

Product integration: Researchers designing growth hormone studies often source compounds like GHRP-2 for direct somatotroph activation or explore synergistic options through Real Peptides' FAT Loss Stack, which pairs metabolic peptides with compounds that support GH pathway efficiency.

Step 2: Start with Micro-Dosing Escalation (Days 1–14)

The single most critical phase of running a VIP cycle is the first two weeks. This is where receptor priming happens, and skipping it is the primary reason protocols fail by week four. Somatotroph cells in the anterior pituitary adapt to exogenous GH secretagogue exposure over time. If you start at full therapeutic dose (300mcg GHRP-2 three times daily), you saturate receptors immediately, triggering downregulation that begins as early as day 10. By week three, your GH response to the same dose has dropped by 40–60%, and you're chasing diminishing returns.

The escalation protocol works like this: Days 1–4, administer 100mcg GHRP-2 and 100mcg GHRP-6 together, three times daily (morning fasted, mid-afternoon at least three hours post-meal, and 30 minutes before bed). Days 5–8, increase to 150mcg per peptide. Days 9–12, move to 200mcg. Days 13–14, reach therapeutic dose at 250–300mcg per peptide. This staged escalation allows somatotroph receptor density to upregulate gradually, maintaining sensitivity across the full eight-week cycle instead of peaking early and crashing.

Timing relative to meals is non-negotiable. Growth hormone release is suppressed by elevated blood glucose and insulin. Administering GHRPs within two hours of a carbohydrate-containing meal reduces GH output by 50–70%. The morning dose should occur immediately upon waking (12+ hour fast), mid-afternoon dose at least three hours after lunch, and evening dose 30–60 minutes before bed on an empty stomach. Research published in the Journal of Clinical Endocrinology & Metabolism confirmed that fasted-state GHRP administration produces 3.2× higher peak GH levels compared to postprandial dosing.

Step 3: Run the Full 8-Week On-Cycle with Injection Discipline

Once you've completed the two-week escalation, you're running therapeutic dose (250–300mcg GHRP-2 and GHRP-6 three times daily) from day 15 through day 56. The mechanism during this phase is pulsatile GH amplification. You're not replacing endogenous production, you're multiplying the amplitude of natural pulses. Peak GH release occurs 15–30 minutes post-injection, which is why timing around circadian GH peaks (largest natural pulse occurs 60–90 minutes after sleep onset) matters.

The bedtime dose is the most anabolic window because it coincides with slow-wave sleep, when the hypothalamus releases its largest GHRH burst. Administering GHRP-2 and GHRP-6 30 minutes before sleep allows the peptide-induced GH pulse to layer on top of the natural nocturnal surge, producing peak serum GH levels 2–4 times higher than baseline. Studies using continuous GH sampling via indwelling catheters show this stacked pulse effect creates a sustained elevation lasting 90–120 minutes. Long enough to drive meaningful IGF-1 synthesis in the liver.

Mid-cycle plateau is common around weeks 4–5. If GH response feels diminished (reduced sleep quality, stalled recovery metrics, loss of the "tightness" in muscle bellies), it's usually due to one of three issues: insufficient fasting windows around doses, cortisol co-release from chronic stress blunting GH signalling, or early receptor desensitisation despite proper escalation. The first is correctable (extend fasting to four hours pre-dose for the afternoon injection). The second requires stress management or temporary dose reduction. The third means you're approaching the ceiling of what this cycle length can deliver. Push to week eight, then off-cycle immediately.

VIP Cycle: Protocol Comparison

Key Takeaways

• GHRP-2 and GHRP-6 amplify endogenous GH pulses through ghrelin receptor (GHS-R1a) activation, producing 3–5× baseline GH peaks when administered fasted.
• Micro-dosing escalation over the first 14 days prevents early receptor desensitisation that kills GH response by week four in protocols starting at full dose.
• Therapeutic dose is 250–300mcg per peptide three times daily, with mandatory fasting windows of at least three hours before each injection to avoid glucose-mediated GH suppression.
• The bedtime dose is the most anabolic window. It layers on top of the natural nocturnal GH surge during slow-wave sleep, producing sustained IGF-1 synthesis.
• Eight weeks on-cycle followed by a mandatory four-week washout allows somatotroph receptor re-sensitisation and prevents long-term pituitary downregulation.
• Mid-cycle plateau around weeks 4–5 typically signals insufficient fasting discipline, cortisol interference, or early receptor fatigue. Not compound degradation.

What If: VIP Cycle Scenarios

What If I Feel No Difference After Two Weeks at Therapeutic Dose?

Verify reconstitution and storage first. GHRP peptides are stable when reconstituted with bacteriostatic water and refrigerated at 2–8°C, but any temperature excursion above 8°C for more than 24 hours causes irreversible degradation. If storage was correct, the issue is usually timing. Administering doses within two hours of meals or during high-cortisol windows (mid-morning after caffeine, late evening after high-stress days) suppresses GH release even when peptides are active. Extend fasting windows to four hours pre-dose and move the afternoon injection to 4–5 PM when cortisol naturally declines.

What If I Experience Severe Water Retention or Joint Pain?

Water retention and carpal tunnel-like symptoms indicate elevated GH is increasing sodium reabsorption in the kidneys and driving extracellular fluid expansion. This is a dose-dependent response, not an adverse reaction. Reduce your therapeutic dose by 25% (drop from 300mcg to 225mcg per peptide) and increase potassium intake to 4–5g daily to counteract sodium retention. If symptoms persist beyond one week at reduced dose, you're either running too high too fast or stacking with compounds (like exogenous insulin or high-dose androgens) that compound fluid retention. VIP cycles alone rarely produce severe edema.

What If I Miss Multiple Doses Mid-Cycle?

Missing one dose per day occasionally won't derail a VIP cycle, but missing two consecutive days resets receptor priming partially. If you miss 48+ hours, drop back to 200mcg per peptide for three days before returning to full therapeutic dose. This re-establishes receptor engagement without overshooting into desensitisation. Do not double-dose to "catch up". GH release is capped by pituitary somatotroph capacity, and exceeding that threshold just increases prolactin and cortisol co-release without additional GH benefit.

The Unflinching Truth About VIP Cycles

Here's the honest answer: most people who run VIP cycles are actually running GHRP-only protocols and calling them "VIP stacks" because the term sounds more advanced. True VIP (vasoactive intestinal peptide) is expensive, degrades in under three minutes, and requires subcutaneous administration within 10–15 minutes of GHRP dosing to produce the dual-pathway amplification effect. If you're not injecting actual VIP. Just GHRP-2, GHRP-6, or a GHRP + GHRH combo. You're running a secretagogue stack, not a VIP cycle. The results are excellent either way, but the labelling matters because VIP-inclusive protocols require tighter timing discipline and shorter cycle lengths (six weeks instead of eight) due to faster receptor adaptation.

The second unspoken reality: GH peptides don't produce dramatic visible changes in the first four weeks. The initial effects are metabolic and recovery-based. Deeper sleep, faster tendon healing, improved glucose partitioning. Body composition changes (fat loss in stubborn depots, increased muscle fullness) become noticeable weeks 5–8, and they're conditional on training stimulus and caloric structure. If you're sedentary or eating maintenance calories, GH elevation won't "melt fat". It shifts substrate utilisation toward fat oxidation during activity and recovery, but you still need a deficit or training load to drive the effect.

The final truth most guides avoid: receptor desensitisation is cumulative across cycles. Running back-to-back eight-week cycles with only four weeks off will eventually produce diminishing returns. By your third or fourth cycle, you'll need 400–500mcg per dose to match the GH response you got from 250mcg in cycle one. The solution is extending off-periods (six to eight weeks between cycles after your second round) or rotating to different receptor pathways (switching to MK-677 for one cycle, then returning to GHRP stacks). Peptides aren't infinite. Respect receptor biology or accept diminishing efficacy.

Running a VIP cycle correctly means starting low, escalating methodically, timing doses around fasted windows and circadian GH peaks, and respecting the eight-week ceiling before mandatory washout. The protocol works. But only if you treat it as a priming strategy, not a saturation protocol. Miss the escalation phase or skip the off-cycle, and you'll plateau before you reach meaningful results. Adhere to receptor physiology, and you'll run multiple productive cycles without chasing doses upward every round.